Oncotarget

Reviews:

Roles of SPARC in urothelial carcinogenesis, progression and metastasis

Neveen Said _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:67574-67585. https://doi.org/10.18632/oncotarget.11590

Metrics: PDF 1246 views  |   HTML 2438 views  |   ?  


Abstract

Neveen Said1

1 Department of Cancer Biology, Wake Forest University Health Sciences, Winston Salem, NC, USA

Correspondence to:

Neveen Said, email:

Keywords: SPARC, urinary bladder, carcinogenesis, cell cycle, inflammation

Received: April 01, 2016 Accepted: July 27, 2016 Published: August 24, 2016

Abstract

Secreted Protein Acidic and Rich in Cysteine (SPARC) is a matricellular glycoprotein that is implicated in myriad physiological and pathological conditions characterized by extensive remodeling and plasticity. The functions and disease association of SPARC in cancer is being increasingly appreciated as it plays multi-faceted contextual roles depending on the cancer type, cell of origin and the unique cancer milieu at both primary and metastatic sites. Herein we will review our current knowledge of the role of SPARC in the multistep cascades of urinary bladder carcinogenesis, progression and metastasis from preclinical models and clinical data and shine the light on its prognostic and therapeutic potentials.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 11590